Develops drugs for obesity, oncology, and infectious diseases.
Jun 2026Revenue $63.7B/yrExpenses $59.5B/yr
No trend
Figures by year
Is Pfizer profitable?
Yes. In the 12 months to Jun 2026, revenue was $63.7B and expenses $59.5B.
| Fiscal year to | Revenue | Expenses | Pre-tax profit |
|---|---|---|---|
| Dec 2025 | $62.6B | $55.1B | $7.52B |
| Dec 2024 | $63.6B | $55.6B | $8.02B |
| Dec 2023 | $59.6B | $58.5B | $1.06B |
| Dec 2022 | $101B | $66.4B | $34.7B |
| Dec 2021 | $81.3B | $57.0B | $24.3B |
| Dec 2020 | $41.7B | $34.6B | $7.04B |
| Dec 2019 | $40.9B | $29.6B | $11.3B |
| Dec 2018 | $40.8B | $37.2B | $3.59B |
| Dec 2017 | $52.5B | $40.2B | $12.3B |
| Dec 2016 | $52.8B | $44.5B | $8.35B |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.